A small chain, a large conversation.
BPC-157 is a lab-made chain of 15 amino acids, the building blocks of proteins. It is based on a fragment of a protein reported in stomach juice. That origin does not make a manufactured product natural or establish that it is safe to use.
It has no FDA-approved medical use. Much of the work behind the interest in recovery has involved animals and cells. Those settings help researchers form questions. They cannot supply an expected result for an injured person.
People are a separate question.
Human evidence is limited. Small reports without a comparison group cannot show whether a change was caused by BPC-157. A comparison group is a similar group that does not receive the substance being tested. Without one, other explanations are hard to separate.
The FDA’s review found that the available human data did not establish safety or effectiveness for the uses it assessed. A small study reporting few problems also cannot rule out uncommon or later harms.
What “withdrawn” means here.
On the FDA’s page current as of April 22, 2026, BPC-157 appears as “nominated but withdrawn.” The nomination was a request for the FDA to consider the ingredient for compounding. Withdrawal of that request is not FDA clearance or approval.
The FDA continues to describe safety concerns beside the entry. These include the possibility of an immune reaction, where the body responds to the peptide as an invader, and problems with impurities. The page does not give a date when each substance changed tables.
Keep a consultation and approval apart.
Promise lists BPC-157 for consultation now. That is a statement about Promise’s service, not evidence that BPC-157 is approved or that every prescription can be prepared. Compounded BPC-157 is not FDA-approved. A pharmacy must make its own decision under the applicable rules.
- What human evidence is relevant to the question I am asking?
- What is unknown about safety over time?
- What approved approaches could also be discussed?
The recovery and peptides guide keeps these questions in a wider frame.